ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,571Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 586

$761K Total Retail Price of All Prescriptions

Rank: 4 out of 586

398 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 398 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

22% of this provider’s 398 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 8,279 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
LEVOTHYROXINE SODIUM 478 370 1 2
HYDROCODONE-ACETAMINOPHEN 432 261 S3 2 5
SIMVASTATIN 386 283 3 1
CITALOPRAM HBR 353 281 4 12
FUROSEMIDE 324 262 5 9
WARFARIN SODIUM 323 246 6 13
METFORMIN HCL 301 182 7 6
POTASSIUM CHLORIDE 299 223 8 14
GABAPENTIN 291 187 9 11
LISINOPRIL 252 189 10 4
LANTUS 252 201 10 33
CYMBALTA 195 93 12 29
ATORVASTATIN CALCIUM 183 138 13 17
AMLODIPINE BESYLATE 168 140 14 7
TRAZODONE HCL 164 103 15 20
OXYCODONE HCL 155 47 S2 16 32
TRAMADOL HCL 152 116 17 15
DIVALPROEX SODIUM 143 93 18 69
QUETIAPINE FUMARATE 136 84 19 50
ALENDRONATE SODIUM 134 92 20 23
OMEPRAZOLE 130 72 21 3
NOVOLOG 130 115 21 106
RAMIPRIL 128 103 23 75
ZOLPIDEM TARTRATE 113 51 24 8
NYSTATIN 109 77 25 153
FLUOXETINE HCL 109 74 25 24
RISPERIDONE 107 105 27 46
SERTRALINE HCL 106 61 28 21
METOPROLOL SUCCINATE 102 98 29 19
SPIRONOLACTONE 99 64 30 76
OXYCODONE HCL-ACETAMINOPHEN 95 23 S2 31 55
PROMETHAZINE HCL 93 35 R 32 86
MIRTAZAPINE 92 56 33 64
DONEPEZIL HCL 91 91 34 40
CEPHALEXIN 90 56 35 105
HYDROCHLOROTHIAZIDE 88 76 36 10
DIOVAN 88 63 36 72
CARVEDILOL 87 68 38 30
ADVAIR DISKUS 84 51 39 59
LOSARTAN POTASSIUM 82 75 40 18
ESCITALOPRAM OXALATE 81 60 41 90
PROPRANOLOL HCL 78 32 42 115
TAMSULOSIN HCL 78 64 42 27
NAMENDA 74 73 44 54
MORPHINE SULFATE ER 73 24 S2 45 49
DIGOXIN 72 71 46 96
LYRICA 71 43 47 87
BACLOFEN 71 33 47 98
RANITIDINE HCL 70 57 49 61
FENOFIBRATE 66 37 50 39
CLOPIDOGREL 66 54 50 71
CELEBREX 61 49 52 44
CIPROFLOXACIN HCL 59 48 53 82
OXYCODONE-ACETAMINOPHEN 58 38 S2 54 78
AZITHROMYCIN 57 26 55 36
SEROQUEL XR 57 28 55 165
NITROFURANTOIN MONO-MACRO 57 38 55 139
LEVOFLOXACIN 56 41 58 146
MELOXICAM 53 20 59 25
CRESTOR 53 32 59 42
CARISOPRODOL 52 21 R 61 57
METOPROLOL TARTRATE 52 36 61 26
GLIPIZIDE 52 16 61 124
CLONIDINE HCL 51 47 64 113
HUMALOG 50 18 65 148
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 21, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.